Sample size and interim analysis issues for dose selection.
Publication
, Journal Article
Lee, KL
Published in: Am Heart J
April 2000
Duke Scholars
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
April 2000
Volume
139
Issue
4
Start / End Page
S161 / S165
Location
United States
Related Subject Headings
- Sample Size
- Randomized Controlled Trials as Topic
- Humans
- Dose-Response Relationship, Drug
- Clinical Trials, Phase III as Topic
- Clinical Trials, Phase II as Topic
- Cardiovascular System & Hematology
- Cardiovascular Agents
- Bias
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, K. L. (2000). Sample size and interim analysis issues for dose selection. Am Heart J, 139(4), S161–S165. https://doi.org/10.1016/s0002-8703(00)90065-6
Lee, K. L. “Sample size and interim analysis issues for dose selection.” Am Heart J 139, no. 4 (April 2000): S161–65. https://doi.org/10.1016/s0002-8703(00)90065-6.
Lee KL. Sample size and interim analysis issues for dose selection. Am Heart J. 2000 Apr;139(4):S161–5.
Lee, K. L. “Sample size and interim analysis issues for dose selection.” Am Heart J, vol. 139, no. 4, Apr. 2000, pp. S161–65. Pubmed, doi:10.1016/s0002-8703(00)90065-6.
Lee KL. Sample size and interim analysis issues for dose selection. Am Heart J. 2000 Apr;139(4):S161–S165.
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
April 2000
Volume
139
Issue
4
Start / End Page
S161 / S165
Location
United States
Related Subject Headings
- Sample Size
- Randomized Controlled Trials as Topic
- Humans
- Dose-Response Relationship, Drug
- Clinical Trials, Phase III as Topic
- Clinical Trials, Phase II as Topic
- Cardiovascular System & Hematology
- Cardiovascular Agents
- Bias
- 3201 Cardiovascular medicine and haematology